临床药代动力学中的非房室模型与房室模型 - Suppr

Suppr

超能文献

Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

作者信息

Gillespie W R

机构信息

Pharmaceutics Division, College of Pharmacy, University of Texas, Austin.

出版信息

Clin Pharmacokinet. 1991 Apr;20(4):253-62. doi: 10.2165/00003088-199120040-00001.

DOI:10.2165/00003088-199120040-00001

PMID:2036746

Abstract

摘要

相似文献

Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

Clin Pharmacokinet. 1991 Apr;20(4):253-62. doi: 10.2165/00003088-199120040-00001.

[Compartmental and noncompartmental kinetic models of blood circulation].

Pol Przegl Radiol Med Nukl. 1971;35(2):219-25.

Statistical considerations in pharmacokinetic study design.

Clin Pharmacokinet. 1993 May;24(5):380-7. doi: 10.2165/00003088-199324050-00003.

Population pharmacokinetics meets microdialysis: benefits, pitfalls and necessities of new analysis approaches for human microdialysis data.

Eur J Pharm Sci. 2014 Jun 16;57:68-73. doi: 10.1016/j.ejps.2013.11.004. Epub 2013 Nov 15.

On the volume of distribution at steady state and its relationship with two-compartmental models.

J Pharm Sci. 2008 Jan;97(1):111-22. doi: 10.1002/jps.21089.

Physiologically based pharmacokinetic/toxicokinetic modeling.

Methods Mol Biol. 2012;929:439-99. doi: 10.1007/978-1-62703-050-2_18.

Modelling the Double Peak Phenomenon in pharmacokinetics.

Comput Methods Programs Biomed. 2011 Nov;104(2):62-9. doi: 10.1016/j.cmpb.2010.03.007. Epub 2010 Apr 8.

Distinguishing animal subsets in toxicokinetic studies: comparison of non-linear mixed effects modelling with non-compartmental methods.

J Appl Toxicol. 2002 Nov-Dec;22(6):437-43. doi: 10.1002/jat.883.

Plasma and cerebrospinal fluid pharmacokinetics of rebeccamycin (NSC 655649) in nonhuman primates.

Cancer Chemother Pharmacol. 2004 Aug;54(2):127-30. doi: 10.1007/s00280-004-0787-0. Epub 2004 May 18.

[Two aspects about curve fitting in pharmacokinetics; weighting of experimental data and discrimination between linear compartmental models (author's transl)].

Yao Xue Xue Bao. 1980 Sep;15(9):571-6.

引用本文的文献

Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: An evaluation of , methodologies and human studies.

Front Pharmacol. 2022 Dec 9;13:1063453. doi: 10.3389/fphar.2022.1063453. eCollection 2022.

Mathematical Modelling for Optimal Vaccine Dose Finding: Maximising Efficacy and Minimising Toxicity.

Vaccines (Basel). 2022 May 11;10(5):756. doi: 10.3390/vaccines10050756.

Liposome-Encapsulated Morphine Affords a Prolonged Analgesia While Facilitating Extinction of Reward and Aversive Memories.

Front Pharmacol. 2019 Sep 20;10:1082. doi: 10.3389/fphar.2019.01082. eCollection 2019.

A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion.

Sci Rep. 2017 Oct 16;7(1):13279. doi: 10.1038/s41598-017-13437-6.

Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging.

Magn Reson Imaging. 2016 Sep;34(7):1034-40. doi: 10.1016/j.mri.2016.04.014. Epub 2016 Apr 22.

Pharmacokinetic modeling of therapies for systemic lupus erythematosus.

Expert Rev Clin Pharmacol. 2015;8(5):587-603. doi: 10.1586/17512433.2015.1059751. Epub 2015 Jul 9.

Microencapsulation Approach for Orally Extended Delivery of Glipizide: In vitro and in vivo Evaluation.

Indian J Pharm Sci. 2012 Jul;74(4):319-30. doi: 10.4103/0250-474X.107063.

Reassessing models of hepatic extraction.

J Biol Phys. 2003 Mar;29(1):1-21. doi: 10.1023/A:1022531403741.

The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics.

Br J Clin Pharmacol. 2012 Dec;74(6):932-9. doi: 10.1111/j.1365-2125.2012.04280.x.

Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats.

Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):53-8. doi: 10.1007/BF03190376.

本文引用的文献

Hepatic clearance theory and clinical application.

Rev Czech Med. 1956;2(1):62-6.

Model-independent method of analyzing input in linear pharmacokinetic systems having polyexponential impulse response I: Theoretical analysis.

J Pharm Sci. 1980 Mar;69(3):298-305. doi: 10.1002/jps.2600690314.

Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.

J Pharmacokinet Biopharm. 1984 Dec;12(6):627-48. doi: 10.1007/BF01059557.

Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin.

Eur J Clin Pharmacol. 1985;29(4):503-9. doi: 10.1007/BF00613469.

A polyexponential deconvolution method. Evaluation of the "gastrointestinal bioavailability" and mean in vivo dissolution time of some ibuprofen dosage forms.

J Pharmacokinet Biopharm. 1985 Jun;13(3):289-307. doi: 10.1007/BF01065657.

A system approach to pharmacodynamics. I: Theoretical framework.

J Pharm Sci. 1988 Jan;77(1):39-47. doi: 10.1002/jps.2600770108.

Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

J Pharmacokinet Biopharm. 1988 Aug;16(4):413-72. doi: 10.1007/BF01062554.

Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part I).

Clin Pharmacokinet. 1989 Nov;17(5):345-66. doi: 10.2165/00003088-198917050-00004.

Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.

Pharm Res. 1991 Feb;8(2):254-8. doi: 10.1023/a:1015860608173.

Volume of distribution as a function of time.

J Pharm Sci. 1976 Mar;65(3):452-4. doi: 10.1002/jps.2600650339.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验